Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

Matching articles

Showing 109–120 of 134 articles · Explore study findings

Clear search and filters

  • Explore study findings

    What the 2026 FDA Appraisal Found About Semax and Stroke

    Semax is a synthetic seven-amino-acid peptide derived in part from a region of adrenocorticotropic hormone. It has been studied in relation to cerebral ischemia, a loss of adequate blood flow to brain tissue.

    Semax2 sources (2018, 2026)

  • Explore study findings

    What the Interim Compounding Policy Actually Covers for Semax

    Semax is a synthetic seven-amino-acid peptide. In 2026, FDA and HHS documents discussed specific Semax-related bulk substances. These sources explain a regulatory context, not a finding that Semax improves memory or recovery.

    Semax3 sources (2026)

  • Explore study findings

    What the FDA's Geref records say about its former indications

    Sermorelin is a synthetic 29-residue fragment of human growth hormone–releasing hormone, with an amidated end. The history of Geref, a U.S. sermorelin acetate product, shows how a diagnostic approval and a treatment approval can address separate questions.

    Sermorelin2 sources (1996, 2013)

  • Explore study findings

    What human liver fractions revealed about SLU-PP-332 breakdown

    SLU-PP-332 is a small synthetic compound with a different chemical structure from a peptide. It activates a group of proteins called estrogen-related receptors. In 2026, two laboratories examined what happened to the compound when exposed to enzymes prepared from human liver tissue.

    SLU-PP-3323 sources (2023, 2026)

  • Explore study findings

    Why SLU-PP-915 results belong to a different compound

    SLU-PP-332 is a synthetic small molecule outside that class. It acts on estrogen-related receptors, which help regulate genes involved in energy metabolism. A recent animal study compared it with another small molecule called SLU-PP-915 and examined which effects were shared.

    SLU-PP-3321 source (2025)

  • Explore study findings

    Which part of an exercise response appeared in mouse muscle?

    SLU-PP-332 is a synthetic small molecule that activates estrogen-related receptors, a family that helps regulate genes involved in muscle metabolism. An older study asked whether one receptor subtype was important for the muscle and endurance responses observed in mice.

    SLU-PP-3321 source (2023)

  • Explore study findings

    What donated skin and volunteer observations each contribute

    SNAP-8 is the name used for acetyl octapeptide-3, a chemically modified cosmetic peptide with eight amino acids. An older paper studied a serum that the authors identified as containing acetyl octapeptide-3 along with other ingredients.

    SNAP-82 sources (2020, 2022)

  • Explore study findings

    Why hydration, skin thickness and fine lines are different outcomes

    SNAP-8 is acetyl octapeptide-3, a modified eight-amino-acid cosmetic ingredient. An older single-center study evaluated a cosmetic patch containing this peptide with several other ingredients. It measured fine lines, hydration and features of deeper skin tissue as separate outcomes.

    SNAP-81 source (2019)

  • Explore study findings

    What the survodutide cardiovascular trial was designed to count

    Survodutide is an investigational peptide that activates the glucagon and GLP-1 receptors. The SYNCHRONIZE cardiovascular study was designed to examine whether cardiovascular events occurred at different rates in adults with excess body weight assigned to survodutide or placebo.

    Survodutide2 sources (2023, 2026)

  • Explore study findings

    Why the two LIVERAGE studies use different liver outcomes

    Survodutide is an investigational peptide that acts on the glucagon and GLP-1 receptors. The LIVERAGE registry records describe two trials that ask different questions about liver disease at different stages of scarring.

    Survodutide3 sources (2024, 2026)

  • Explore study findings

    What the Chinese and Japanese trials tell us about who was studied

    Survodutide is an investigational peptide that acts at glucagon and GLP-1 receptors. Two 2026 design reports described how researchers set up randomized weight-management trials in China and Japan, including who could enroll and when outcomes would be measured.

    Survodutide2 sources (2026)

  • Explore study findings

    What an MRI showed about liver fat in SYNCHRONIZE-MASLD

    Survodutide is an investigational glucagon and GLP-1 receptor agonist peptide. A phase 3 study reported in 2026 asked whether it changed liver fat and body weight in adults with obesity and at-risk metabolic dysfunction-associated steatotic liver disease, or MASLD.

    Survodutide2 sources (2024, 2026)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)